Literature DB >> 1550812

Energetics of a hexagonal-lamellar-hexagonal-phase transition sequence in dioleoylphosphatidylethanolamine membranes.

K Gawrisch1, V A Parsegian, D A Hajduk, M W Tate, S M Graner, N L Fuller, R P Rand.   

Abstract

The phase diagram of DOPE/water dispersions was investigated by NMR and X-ray diffraction in the water concentration range from 2 to 20 water molecules per lipid and in the temperature range from -5 to +50 degrees C. At temperatures above 22 degrees C, the dispersions form an inverse (HII) phase at all water concentrations. Below 25 degrees C, an HII phase occurs at high water concentrations, an L alpha phase is formed at intermediate water concentrations, and finally the system switches back to an HII phase at low water concentrations. The enthalpy of the L alpha-HII-phase transition is +0.3 kcal/mol as measured by differential scanning calorimetry. Using 31P and 2H NMR and X-ray diffraction, we measured the trapped water volumes in HII and L alpha phases as a function of osmotic pressure. The change of the HII-phase free energy as a function of hydration was calculated by integrating the osmotic pressure vs trapped water volume curve. The phase diagram calculated on the basis of the known enthalpy of transition and the osmotic pressure vs water volume curves is in good agreement with the measured one. The HII-L alpha-HII double-phase transition at temperatures below 22 degrees C can be shown to be a consequence of (i) the greater degree of hydration of the HII phase in excess water and (ii) the relative sensitivities with which the lamellar and hexagonal phases dehydrate with increasing osmotic pressure. These results demonstrate the usefulness of osmotic stress measurements to understand lipid-phase diagrams.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1550812     DOI: 10.1021/bi00126a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  43 in total

1.  Theory of lipid polymorphism: application to phosphatidylethanolamine and phosphatidylserine.

Authors:  X Li; M Schick
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

2.  Stalk model of membrane fusion: solution of energy crisis.

Authors:  Yonathan Kozlovsky; Michael M Kozlov
Journal:  Biophys J       Date:  2002-02       Impact factor: 4.033

3.  A rhombohedral phase of lipid containing a membrane fusion intermediate structure.

Authors:  Lin Yang; Huey W Huang
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

4.  Molecular view of hexagonal phase formation in phospholipid membranes.

Authors:  Siewert-Jan Marrink; Alan E Mark
Journal:  Biophys J       Date:  2004-09-17       Impact factor: 4.033

5.  Stalk phase formation: effects of dehydration and saddle splay modulus.

Authors:  Yonathan Kozlovsky; Avishay Efrat; David P Siegel; David A Siegel; Michael M Kozlov
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

6.  Bending free energy from simulation: correspondence of planar and inverse hexagonal lipid phases.

Authors:  Alexander J Sodt; Richard W Pastor
Journal:  Biophys J       Date:  2013-05-21       Impact factor: 4.033

7.  Membrane fusion intermediates and the effect of cholesterol: an in-house X-ray scattering study.

Authors:  S Aeffner; T Reusch; B Weinhausen; T Salditt
Journal:  Eur Phys J E Soft Matter       Date:  2009-10       Impact factor: 1.890

Review 8.  Molecular Dynamics Simulations of Membrane Permeability.

Authors:  Richard M Venable; Andreas Krämer; Richard W Pastor
Journal:  Chem Rev       Date:  2019-02-12       Impact factor: 60.622

9.  The Surface and Hydration Properties of Lipid Droplets.

Authors:  Siyoung Kim; Jessica M J Swanson
Journal:  Biophys J       Date:  2020-10-14       Impact factor: 4.033

10.  Viral fusion protein transmembrane domain adopts β-strand structure to facilitate membrane topological changes for virus-cell fusion.

Authors:  Hongwei Yao; Michelle W Lee; Alan J Waring; Gerard C L Wong; Mei Hong
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.